Furthermore, and as it was the case for POMT1/2, the POMGNT1 gene was found upregulated at the mRNA level in renal cell carcinoma (by 1.20-fold) [76] and primary blasts derived from patients with AML (by 1.85-fold) [77]. The gene discussed is POMGNT1; the disease is acute myeloid leukemia.